Lung Volume Reduction Surgery

Medicare beneficiaries with emphysema who received an endobronchial valve vs. lung volume reduction surgery faced elevated risk-adjusted odds for poor outcomes, according to data presented at the Society of Thoracic Surgeons Annual Meeting.

Patients with severe emphysema had lasting lung function improvement 5 years after bronchoscopic lung volume reduction with Zephyr Valves, according to a poster presented at the European Respiratory Society International Congress.